Category: Atomic Spectroscopy
PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research Forward
New kit provides highly sensitive and efficient approach for studying mitophagyimpairment in conditions such as Parkinson’s and Alzheimer’s WALTHAM, Mass. – October 26, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective... Read more
Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System
ZUERICH–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announces the European launch of the high-performance Fourier™ 80 system, a next-generation, 80 MHz Fourier Transform Nuclear Magnetic Resonance (FT-NMR) benchtop spectrometer, now with major new capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005105/en/ The new Fourier 80 brings the power of NMR to the... Read more
QIAGEN to complement COVID-19 testing portfolio with novel kit that simplifies and accelerates PCR analysis for research applications
Hilden, Germany, and Germantown, Maryland, October 5, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and remove key testing bottlenecks for SARS-CoV-2 and other RNA viruses. QIAGEN’s innovative QIAprep& Viral RNA UM Kit... Read more
PerkinElmer Signals Notebook and PerkinElmer Signals Medical Review Cloud-Based Software Gain SOC 2 Attestation for Biopharmaceutical Research and Clinical Trial Data
Company’s Informatics Solutions Meet AICPA’s Trust Service Principles for Security, Confidentiality & Availability WALTHAM, Mass. – September 30, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for... Read more
GE Healthcare to collaborate with French SMEs, start-ups, research labs and clinical centers to help accelerate AI development in imaging
Buc, France – September 29, 2020 – GE Healthcare announces the launch of the AI DReAM project, a consortium that gathers French SMEs, start-ups, research labs and clinical centers to facilitate the development of AI in medical imaging. Supported with €13 million by the “Investments for the Future” program (PIA), led by the French General... Read more
Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies
Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies CARLSBAD, Calif., Sept. 23, 2020 /PRNewswire/ — Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies... Read more
QIAGEN expands integrated coronavirus NGS and software solutions to accelerate COVID-19 research
Hilden, Germany, and Germantown, Maryland, August 18, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with integrated analysis and interpretation workflows for insights into the evolution and spread of the virus that causes COVID-19 disease. The new... Read more
Thermo Fisher and Leading Contract Research Organizations Expand Cryo-EM Access to More Pharma and Biotech Companies
New program helps break down information barriers to cryo-EM adoption to speed development of more effective drugs Read more
Brain Gain: Stunning new MRI tech advances neuro research and clinical translation capabilities at #ISMRM20
Waukesha, WI – August 10, 2020 – At this year’s virtual ISMRM meeting, GE Healthcare is showcasing new technologies to enable neuro research to better understand Alzheimer’s disease and traumatic brain injury, as well as accelerate clinical translation. The 510(k)-pending SIGNA 7.0T [1], as well as research devices SIGNA ultra-high performance (UHP) 3.0T and the... Read more